AMITYVILLE, N.Y. Hi-Tech Pharmacal on Wednesday named Kamel Egbaria as the company’s chief scientific officer.
“We welcome [Egbaria] to our management team and believe that his experience will help Hi-Tech Pharmacal grow and achieve continued success,” stated David Seltzer, president and CEO at Hi-Tech.
Egbaria has more than 25 years of experience in pharmaceutical management and research. He joins Hi-Tech Pharmacal from Qualitest Pharmaceuticals, where he served most recently as chief scientific officer and VP of research and development.
Egbaria earned a Ph.D. in pharmaceutics from Hebrew University in Jerusalem, Israel.